Checkpoint Therapeutics CEO James Oliviero's 2022 pay slips 11% to $2M
Checkpoint Therapeutics reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
Checkpoint Therapeutics reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, two executives at Checkpoint Therapeutics received on average a compensation package of $1.4M, a 9% increase compared to previous year.
Average pay of disclosed executives at Checkpoint Therapeutics
James F. Oliviero III, Chief Executive Officer, received $2M in total, which decreased by 11% compared to 2021. 56% of Oliviero's compensation, or $1.2M, was in stock awards. Oliviero also received $297K in non-equity incentive plan and $594K in salary.
Garrett Gray, Chief Financial Officer, received a compensation package of $712K, which decreased by 5% compared to previous year. 49% of the compensation package, or $347K, was in stock awards.
Related executives
You may also like
Source: SEC filing on May 1, 2023.